The Newborn Screening Market Size is valued at 935.17 Million in 2022 and is predicted to reach 2113.45 Million by the year 2031 at a 9.8 % CAGR during the forecast period for 2023-2031.
During the newborn screening, conditions that may have an impact on a child's long-term health or survival are discovered. Children can achieve their full potential when they receive early identification, diagnosis, and intervention. Before being released from a hospital or birthing centre, millions of babies in the U.S. undergo routine screening for certain genetic, endocrine, and metabolic disorders using a few drops of blood from the newborn's heel.
The newborn screening market is expected to be significantly influenced by an expanding neonatal population, an increase in the prevalence of congenital illnesses in infants, favorable government policies and laws, and technical improvements. One of the leading market drivers is the increase in the number of newborns. The world population metre is increasing, which further boosts the market. Organizations like the WHO, CDC, Healthy Newborn Network, etc., are working to inform parents about potential problems and associated testing methods to stop this number from rising. Furthermore, due to COVID-19, there was a decline in the market in 2020, but the market rebounded in 2021 with increasing awareness among the people regarding child safety and preventive measures.
The newborn screening market is segmented by technology into pulse oximetry, tandem mass spectrometry, enzyme and DNA-based tests, and electrophoresis. Tandem mass spectrometry (TMS), a cutting-edge analytical tool used in labs to examine bodily fluids and other pollutants, can assess these substances. Due to its strong demand, cost-effectiveness, broad applicability, and technological advancements, tandem mass spectrometry has the highest share. Due to its superior ability to diagnose a variety of problems in a single operation, tandem spectroscopy (MS/MS) is also anticipated to rise in the coming years.
By products, the market is divided into instruments, reagents, assay kits and others. By Application, the market is divided into dry blood spot tests, critical congenital heart disease, hearing screens and others. Regionally, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America region is anticipated to dominate this market over the forecast years.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 935.17 Million |
|
Revenue Forecast In 2031 |
USD 2113.45 Million |
|
Growth Rate CAGR |
CAGR of 9.8 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Technology, By Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Perkinelmer, Inc., Waters Corporation, Natus Medical Incorporated, Ab Sciex LLC, Masimo Corporation, Bio-Rad Laboratories, Inc., Covidien Plc, Ge Healthcare, Trivitron Healthcare and Agilent Technologies Inc and other prominent players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Newborn Screening Market Snapshot
Chapter 4. Global Newborn Screening Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2030
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Product Type:
5.2.1. Instruments
5.2.2. Reagents
5.2.3. Assay kits
5.2.4. Others
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2030
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Technology:
6.2.1. Tandem Mass Spectrometry
6.2.2. Pulse Oximetry
6.2.3. Enzyme Based Essay
6.2.4. DNA Assay
6.2.5. Electrophoresis
6.2.6. Others
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2030
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:
7.2.1. Dry Blood Spot Test
7.2.2. Critical Congenital Heart Diseases
7.2.3. Hearing screen
7.2.4. Others
Chapter 8. Newborn Screening Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Newborn Screening Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030
8.1.2. North America Newborn Screening Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2030
8.1.3. North America Newborn Screening Market revenue (US$ Million) by Application, 2022-2030
8.1.4. North America Newborn Screening Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030
8.2. Europe
8.2.1. Europe Newborn Screening Market revenue (US$ Million) by Product Type, 2022-2030
8.2.2. Europe Newborn Screening Market revenue (US$ Million) by Technology, 2022-2030
8.2.3. Europe Newborn Screening Market revenue (US$ Million) by Application, 2022-2030
8.2.4. Europe Newborn Screening Market revenue (US$ Million) by country, 2022-2030
8.3. Asia Pacific
8.3.1. Asia Pacific Newborn Screening Market revenue (US$ Million) by Product Type, 2022-2030
8.3.2. Asia Pacific Newborn Screening Market revenue (US$ Million) by Technology, 2022-2030
8.3.3. Asia-Pacific Newborn Screening Market revenue (US$ Million) by Application, 2022-2030
8.3.4. Asia Pacific Newborn Screening Market revenue (US$ Million) by country, 2022-2030
8.4. Latin America
8.4.1. Latin America Newborn Screening Market revenue (US$ Million) by Product Type, 2022-2030
8.4.2. Latin America Newborn Screening Market revenue (US$ Million) by Technology, 2022-2030
8.4.3. Latin America Newborn Screening Market revenue (US$ Million) by Application, 2022-2030
8.4.4. Latin America Newborn Screening Market revenue (US$ Million) by country, 2022-2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Newborn Screening Market revenue (US$ Million) by Product Type, 2022-2030
8.5.2. Middle East & Africa Newborn Screening Market revenue (US$ Million) by Technology, 2022-2030
8.5.3. Middle East & Africa Newborn Screening Market revenue (US$ Million) by Application, 2022-2030
8.5.4. Middle East & Africa Newborn Screening Market revenue (US$ Million) by country, 2022-2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Perkinelmer, Inc.
9.2.2. Waters Corporation
9.2.3. Natus Medical Incorporated
9.2.4. Ab Sciex LLC
9.2.5. Masimo Corporation
9.2.6. Bio-Rad Laboratories, Inc.
9.2.7. Covidien Plc
9.2.8. Ge Healthcare
9.2.9. Trivitron Healthcare
9.2.10. Agilent Technologies Inc
9.2.11. Other Prominent Players
Global Newborn Screening Market, (Value US$ Million) 2019 to 2030 based on Technology,
The Global Newborn Screening Market Estimates (Value US$ Million) 2019 to 2030 based on Products,
The Global Newborn Screening Market Estimates (Value US$ Million) 2019 to 2030 based on Application,
Global Newborn Screening Market, by Region, 2020-2030 (Value US$ Mn)
North America Newborn Screening Market, by Country, 2020-2030 (Value US$ Mn)
Europe Newborn Screening Market, by Country, 2020-2030 (Value US$ Mn)
Asia Pacific Newborn Screening Market, by Country, 2020-2030 (Value US$ Mn)
Latin America Newborn Screening Market, by Country, 2020-2030 (Value US$ Mn)
Middle East & Africa Newborn Screening Market, by Country, 2020-2030 (Value US$ Mn)
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
